Little research has been performed to understand the specific rules and
mechanisms of minimal residual disease, including clonal evolution at the metastatic site,
epigenetic programs, interaction with organ defense and immune systems,
mechanisms of dormancy and re-awakening, and last but not least,
mechanisms of therapy
resistance in specific niches.